FDA Webview
X

Free FDA Notices

Comments Sought on Info on BLA Licensing

06/12/2013

Federal Register Notice: FDA is seeking public comment on the collection of information on to general licensing provisions for BLAs, changes to an approved application, labeling, revocation and suspension, postmarketing studies status reports, and Forms FDA 356h and 2567. Comments should be submitted by 8/12. To view this notice, click here.

LATEST NEWS